Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy

Maiko Takita, Eisuke Iwasaki, Ken Hatogai, Ryohei Kishino, Eri Seki, Motoko Izumiya, Norio Maeda, Atsushi Nakazawa, Akira Mizuki, Kan Handa, Yutaka Shimoyama, Kiyoshi Mukai, Hajime Higuchi, Hiromasa Takaishi, Toshifumi Hibi, Nobuhiro Tsukada

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A 57-year-old man with advanced gallbladder cancer and accompanying hepatic, colonic and duodenal invasion and para-aortic lymph node metastasis was referred to our hospital. Gemcitabine plus S-1 administration was chosen. Gemcitabine was administered intravenously at a dose of 1000mg/m 2 on days 1 and 15, and repeated every 4 weeks. S-1 was administered orally at a dose of 40mg/m 2 bid. on days 1-14. Chemotherapy was effective for the primary gallbladder tumor and lymph node metastasis. The primary tumor and metastatic lymph nodes were shown to have disappeared by a FDG-PET CT study after 10 courses of chemotherapy. Informed consent was obtained prior to performing surgery of the primary lesion. Pathological examination showed fibrosis and a small focus of residual cancer in the resected gallbladder. Complete resection was achieved as all the margins were negative. The findings suggest that gemcitabine plus S-1 treatment may be effective against advanced gallbladder cancer.

Original languageEnglish
Pages (from-to)1263-1270
Number of pages8
JournalJournal of Japanese Society of Gastroenterology
Volume108
Issue number7
Publication statusPublished - 2011 Jul

Fingerprint

gemcitabine
Gallbladder Neoplasms
Lymph Nodes
Gallbladder
Drug Therapy
Neoplasm Metastasis
Residual Neoplasm
Informed Consent
Neoplasms
Fibrosis
Liver

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Takita, M., Iwasaki, E., Hatogai, K., Kishino, R., Seki, E., Izumiya, M., ... Tsukada, N. (2011). Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy. Journal of Japanese Society of Gastroenterology, 108(7), 1263-1270.

Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy. / Takita, Maiko; Iwasaki, Eisuke; Hatogai, Ken; Kishino, Ryohei; Seki, Eri; Izumiya, Motoko; Maeda, Norio; Nakazawa, Atsushi; Mizuki, Akira; Handa, Kan; Shimoyama, Yutaka; Mukai, Kiyoshi; Higuchi, Hajime; Takaishi, Hiromasa; Hibi, Toshifumi; Tsukada, Nobuhiro.

In: Journal of Japanese Society of Gastroenterology, Vol. 108, No. 7, 07.2011, p. 1263-1270.

Research output: Contribution to journalArticle

Takita, M, Iwasaki, E, Hatogai, K, Kishino, R, Seki, E, Izumiya, M, Maeda, N, Nakazawa, A, Mizuki, A, Handa, K, Shimoyama, Y, Mukai, K, Higuchi, H, Takaishi, H, Hibi, T & Tsukada, N 2011, 'Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy', Journal of Japanese Society of Gastroenterology, vol. 108, no. 7, pp. 1263-1270.
Takita, Maiko ; Iwasaki, Eisuke ; Hatogai, Ken ; Kishino, Ryohei ; Seki, Eri ; Izumiya, Motoko ; Maeda, Norio ; Nakazawa, Atsushi ; Mizuki, Akira ; Handa, Kan ; Shimoyama, Yutaka ; Mukai, Kiyoshi ; Higuchi, Hajime ; Takaishi, Hiromasa ; Hibi, Toshifumi ; Tsukada, Nobuhiro. / Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy. In: Journal of Japanese Society of Gastroenterology. 2011 ; Vol. 108, No. 7. pp. 1263-1270.
@article{9b3616c8741b4cf28a68a660f0bd1f52,
title = "Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy",
abstract = "A 57-year-old man with advanced gallbladder cancer and accompanying hepatic, colonic and duodenal invasion and para-aortic lymph node metastasis was referred to our hospital. Gemcitabine plus S-1 administration was chosen. Gemcitabine was administered intravenously at a dose of 1000mg/m 2 on days 1 and 15, and repeated every 4 weeks. S-1 was administered orally at a dose of 40mg/m 2 bid. on days 1-14. Chemotherapy was effective for the primary gallbladder tumor and lymph node metastasis. The primary tumor and metastatic lymph nodes were shown to have disappeared by a FDG-PET CT study after 10 courses of chemotherapy. Informed consent was obtained prior to performing surgery of the primary lesion. Pathological examination showed fibrosis and a small focus of residual cancer in the resected gallbladder. Complete resection was achieved as all the margins were negative. The findings suggest that gemcitabine plus S-1 treatment may be effective against advanced gallbladder cancer.",
author = "Maiko Takita and Eisuke Iwasaki and Ken Hatogai and Ryohei Kishino and Eri Seki and Motoko Izumiya and Norio Maeda and Atsushi Nakazawa and Akira Mizuki and Kan Handa and Yutaka Shimoyama and Kiyoshi Mukai and Hajime Higuchi and Hiromasa Takaishi and Toshifumi Hibi and Nobuhiro Tsukada",
year = "2011",
month = "7",
language = "English",
volume = "108",
pages = "1263--1270",
journal = "Journal of Japanese Society of Gastroenterology",
issn = "0446-6586",
publisher = "Japanese Society of Gastroenterology",
number = "7",

}

TY - JOUR

T1 - Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy

AU - Takita, Maiko

AU - Iwasaki, Eisuke

AU - Hatogai, Ken

AU - Kishino, Ryohei

AU - Seki, Eri

AU - Izumiya, Motoko

AU - Maeda, Norio

AU - Nakazawa, Atsushi

AU - Mizuki, Akira

AU - Handa, Kan

AU - Shimoyama, Yutaka

AU - Mukai, Kiyoshi

AU - Higuchi, Hajime

AU - Takaishi, Hiromasa

AU - Hibi, Toshifumi

AU - Tsukada, Nobuhiro

PY - 2011/7

Y1 - 2011/7

N2 - A 57-year-old man with advanced gallbladder cancer and accompanying hepatic, colonic and duodenal invasion and para-aortic lymph node metastasis was referred to our hospital. Gemcitabine plus S-1 administration was chosen. Gemcitabine was administered intravenously at a dose of 1000mg/m 2 on days 1 and 15, and repeated every 4 weeks. S-1 was administered orally at a dose of 40mg/m 2 bid. on days 1-14. Chemotherapy was effective for the primary gallbladder tumor and lymph node metastasis. The primary tumor and metastatic lymph nodes were shown to have disappeared by a FDG-PET CT study after 10 courses of chemotherapy. Informed consent was obtained prior to performing surgery of the primary lesion. Pathological examination showed fibrosis and a small focus of residual cancer in the resected gallbladder. Complete resection was achieved as all the margins were negative. The findings suggest that gemcitabine plus S-1 treatment may be effective against advanced gallbladder cancer.

AB - A 57-year-old man with advanced gallbladder cancer and accompanying hepatic, colonic and duodenal invasion and para-aortic lymph node metastasis was referred to our hospital. Gemcitabine plus S-1 administration was chosen. Gemcitabine was administered intravenously at a dose of 1000mg/m 2 on days 1 and 15, and repeated every 4 weeks. S-1 was administered orally at a dose of 40mg/m 2 bid. on days 1-14. Chemotherapy was effective for the primary gallbladder tumor and lymph node metastasis. The primary tumor and metastatic lymph nodes were shown to have disappeared by a FDG-PET CT study after 10 courses of chemotherapy. Informed consent was obtained prior to performing surgery of the primary lesion. Pathological examination showed fibrosis and a small focus of residual cancer in the resected gallbladder. Complete resection was achieved as all the margins were negative. The findings suggest that gemcitabine plus S-1 treatment may be effective against advanced gallbladder cancer.

UR - http://www.scopus.com/inward/record.url?scp=79960734194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960734194&partnerID=8YFLogxK

M3 - Article

VL - 108

SP - 1263

EP - 1270

JO - Journal of Japanese Society of Gastroenterology

JF - Journal of Japanese Society of Gastroenterology

SN - 0446-6586

IS - 7

ER -